These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15201662)

  • 21. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation.
    Mücke VT; Gerharz J; Jakobi K; Thomas D; Ferreirós Bouzas N; Mücke MM; Trötschler S; Weiler N; Welker MW; Zeuzem S; Pfeilschifter J; Grammatikos G
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of monitoring serum level of matrix metalloproteinase 9 in patients with acute kidney allograft rejection.
    Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
    Transplant Proc; 2015 Mar; 47(2):319-22. PubMed ID: 25769566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies.
    Huang CY; Tseng KC; Lin MN; Tsai JP; Su CC
    J Clin Pathol; 2015 Nov; 68(11):917-22. PubMed ID: 26246386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Orthotopic liver transplantation (first clinical experience)].
    Konstantinov BA; Eramishantsev AK; Goté SV; Tsirulńikova OM; Skipenko OG; Lebezev VM; Shertsinger AG; Lokshin LS
    Khirurgiia (Mosk); 1993 Mar; (3):32-44. PubMed ID: 8089967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining.
    Endo T; Nakabayashi K; Sekiuchi M; Kuroda T; Soejima A; Yamada A
    Clin Exp Nephrol; 2006 Dec; 10(4):253-61. PubMed ID: 17186329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid.
    Niimi Y; Pawankar R; Kawana S
    Int Arch Allergy Immunol; 2006; 139(2):104-13. PubMed ID: 16374020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.
    Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Pons-Romero F
    Liver Transpl; 2009 Jun; 15(6):629-33. PubMed ID: 19479806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.
    Korkmaz KS; de Rooij BJ; van Hoek B; Janse M; Coenraad MJ; van der Reijden JJ; Weersma RK; Porte RJ; Voorneveld PW; Baranski AG; Verspaget HW
    Liver Int; 2014 Feb; 34(2):274-80. PubMed ID: 23809662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.